Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Antares Pharma Inc.
Primary objective:
\- To assess the safe usability of the VIBEX MTX device for subcutaneous (SC) self-injection of methotrexate (MTX) in adult patients with rheumatoid arthritis (RA) after standardized training by site personnel and review of written instructions
Secondary objectives:
* To evaluate the reliability and robustness of the VIBEX MTX device
* To evaluate the safety and local tolerance of an SC self-injection of MTX using the VIBEX MTX device
* To evaluate the effectiveness and ease of use of the VIBEX MTX device patient education tools for SC self-injection
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female patients \>18 years of age, diagnosed with Rheumatoid Arthritis
You may not be if
Pregnant females
Any other clinically significant disease or disorder which, in the opinion of the investigator might put the subject at risk
